Classification of current anticancer immunotherapies

Lorenzo Galluzzi 1, 2 Erika Vacchelli 1 José-Manuel Bravo-San Pedro 1 Aitziber Buqué 1 Laura Senovilla 1 Elisa Elena Baracco 3, 1 Norma Bloy 1, 3 Francesca Castoldi 1, 3, 4 Jean-Pierre Abastado 5 Patrizia Agostinis 6 Fernando Aranda 1, 7 Maha Ayyoub 8, 9 Philipp Beckhove 10 Jean-Yves Blay 11 Laura Bracci 12 Anne Caignard 13 Chiara Castelli 14 Federica Cavallo 15 Estaban Celis 16 Vincenzo Cerundolo 17 Aled Clayton 18, 19, 20 Mario Colombo 14 Lisa Coussens 21 Madhav Dhodapkar 22 Alexander Eggermont 23 Douglas Fearon 24 Wolf Fridman 25 Kitka Fučíková 4, 26 Dmitry Gabrilovich 27 Jérôme Galon 25 Abhishek Garg 6 François Ghiringhelli 28 Giuseppe Giaccone 29, 30 Eli Gilboa 31 Sacha Gnjatic 31 Axel Hoos 32 Anne Hosmalin 33 Dirk Jäger 34 Pawel Kalinski 35, 36, 37 Klas Kärre 38 Oliver Kepp 36, 39 Rolf Kiessling 40 John Kirkwood 41 Eva Klein 38 Alexander Knuth 36 Claire Lewis 42 Roland Liblau 43 Michael Lotze 36, 35 Enrico Lugli 44 Jean-Pierre Mach 45 Fabrizio Mattei 12 Domenico Mavilio 44, 46 Ignacio Melero 47, 48 Cornelis Melief 49, 50 Elizabeth Mittendorf 51 Lorenzo Moretta 52 Adekunke Odunsi 53 Hideho Okada 54 Anna Karolina Paluka 55 Marcus Peter 56 Kenneth Pienta 57 Angel Porgador 58 George Prendergast 59 Gabriel Rabinovich 60 Nicholas Restifo 61 Naiyer Rizvi 62 Catherine Sautès-Fridman 25 Hans Schreiber 63 Barbara Seliger 64 Hiroshi Shiku 65 Bruno Silva-Santos 66 Mark Smyth 67, 68 Daniel Speiser 69, 70 Radek Spisek 4, 26 Pramod Srivastava 71, 72 James Talmadge 73 Eric Tartour 74, 75 Sjoerd Van Der Burg 76 Benoît Van den Eynde 77, 78, 79 Richard Vile 80 Hermann Wagner 81 Jeffrey Weber 82 Theresa Whiteside 35, 83 Jedd Wolchok 84, 85 Laurence Zitvogel 86, 87 Weiping Zou 88 Guido Kroemer 1, 2, 89
1 Equipe labellisée Ligue contre le cancer - CRC - Inserm U1138 - Apoptose, cancer et immunité
IGR - Institut Gustave Roussy, CRC - Centre de Recherche des Cordeliers
2 UPD5 - Université Paris Descartes - Paris 5
3 UP11 - Université Paris-Sud - Paris 11
4 Sotio a.c.
5 Pole d’innovation thérapeutique en oncologie
6 Cell Death Research and Therapy (CDRT) Laboratory
7 Group of Immune receptors of the Innate and Adaptive System
8 ICO Nantes - Institut de cancérologie de l'Ouest - Nantes
9 Cancer Vaccines and Immune Regulation
10 Translational Immunology Division
11 CRCL - Centre de Recherche en Cancérologie de Lyon
12 Dept. of Hematology, Oncology and Molecular Medicine
13 A2T - Alloimmunité-Autoimmunité-Transplantation
14 Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine
15 Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences
16 Cancer Immunology, Inflammation and Tolerance Program
17 MRC Human Immunology Unit
18 Department of Oncology - Pathology
19 Institute of Cancer & Genetics
20 Velindre Cancer Centre
21 Knight Cancer Institute
22 Sect. of Hematology and Immunobiology,Yale Cancer Center
23 IGR - Institut Gustave Roussy
24 Cold Spring Harbor Laboratory, NY
25 CRC - Centre de Recherche des Cordeliers
26 Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol
27 Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine
28 CRLCC - CGFL - Centre Régional de Lutte contre le cancer - Centre Georges-François Leclerc
29 Center for Cancer Research, National Cancer Institute (NCI)
30 Lombardi Comprehensive Cancer Center
31 Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center
32 Glaxo Smith Kline, Cancer Immunotherapy Consortium
33 UM3 (UMR 8104 / U1016) - Institut Cochin
34 National Center for Tumor Diseases
35 Hillman Cancer Center
36 Department of Surgery
37 Dept. of Immunology and Infectious Diseases and Microbiology
38 Dept. of Microbiology, Tumor and Cell Biology
39 Plateforme de métabolomique
Direction de la recherche [Gustave Roussy]
40 Dept. of Oncology
41 Cancer Institute Laboratory
42 Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology
43 CPTP - Centre de Physiopathologie de Toulouse Purpan
44 Unit of Clinical and Experimental Immunology
45 Institut de Biochimie
46 Dept. of Medical Biotechnologies and Translational Medicine
47 Dept. of Immunology, Centro de Investigación Médica Aplicada (CIMA)
48 Dept. of Oncology
49 ISA Therapeutics
50 Dept. of Immunohematology and Blood Transfusion
51 Research Dept. of Surgical Oncology
52 Istituto Giannina Gaslini
53 Center for Immunotherapy
54 Dept. of Neurological Surgery
55 The Jackson Laboratory for Genomics Medicine
56 Div. of Hematology/Oncology
57 The James Buchanan Brady Urological Institute
58 Shraga Segal Department of Microbiology and Immunology
59 Cell Biology and Signaling Program
60 Laboratorio de Inmunopatología
61 National Cancer Institute (NCI)
62 MSKCC - Memorial Sloan Kettering Cancer Center
63 Dept. of Pathology, The Cancer Research Center
64 Institute of Medical Immunology
65 Department of Immuno-gene Therapy
66 Instituto de Medicina Molecular
67 Immunology in Cancer and Infection Laboratory
68 School of Medicine
69 Dept. of Oncology
70 Ludwig Cancer Research Center
71 Dept. of Immunology
72 Carole and Ray Neag Comprehensive Cancer Center
73 Laboratory of Transplantation Immunology, Dept. of Pathology and Microbiology
74 PARCC - U970 - Paris-Centre de Recherche Cardiovasculaire
75 Service d'immunologie biologique
76 Dept. of Clinical Oncology
77 UCL - Université Catholique de Louvain
78 Ludwig Institute for Cancer Research
79 de Duve Institute
80 Dept. of Molecular Medicine and Immunology
81 Institute of Medical Microbiology, Immunology and Hygiene
82 Donald A. Adam Comprehensive Melanoma Research Center
83 University of Pittsburgh School of Medicine
84 Dept. of Medicine and Ludwig Center
85 Weill Medical College of Cornell University [New York]
86 CIC 1428 , CBT 507 - Centre d'Investigation Clinique en Biotherapie des cancers
87 UMR 1015 - Immunologie des tumeurs et immunothérapie
88 Medical School
89 Pôle de biologie
Abstract : NA
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2014, pp.12472-508
Liste complète des métadonnées
http://www.hal.inserm.fr/inserm-01142463
Contributeur : Mireille Bos <>
Soumis le : mercredi 15 avril 2015 - 11:46:36
Dernière modification le : mardi 18 septembre 2018 - 13:10:03

Fichier

2998-36904-3-PB.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-01142463, version 1
  • PUBMED : 25537519

Collections

UPMC | FNCLCC | CGFL | IGR | ICO | PAPIN | GAUDUCHEAU | CORDELIERS | UNIV-NANTES | UNIV-PARIS5 | UNIV-TLSE3 | PSL | USPC | UNIV-LYON1 | CRCL

Citation

Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, et al.. Classification of current anticancer immunotherapies. Oncotarget, Impact journals, 2014, pp.12472-508. 〈inserm-01142463〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

902

Téléchargements de fichiers

577

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD